Godelieve Verplancke
Director/Board Member at MATERIALISE NV
Net worth: - $ as of 2024-05-30
Profile
Godelieve Verplancke was the founder of Qaly (founded in 2013) and Qaly-Co BV (founded in 2013), where she held the title of Managing Director.
She is currently working as an Independent Non-Executive Director at MDxHealth SA since 2017, as an Independent Director at Materialise NV since 2015, and as a Director at Fondation contre le Cancer.
In her former positions, she worked as a Managing Director at Merck & Co., Inc., as a Director at Euronext Brussels SA, as an Independent Director at Quest for Growth NV, as a Managing Director at Bristol-Myers Squibb Belgium SA, and as a Director at Stichting Tegen Kanker and Imelda Hospital.
Dr. Verplancke obtained a doctorate degree from Katholieke Universiteit Leuven and holds graduate and MBA degrees from the University of Antwerp.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MDXHEALTH S.A.
-.--% | 2023-03-30 | 0 ( -.--% ) | - $ | 2024-05-30 |
Godelieve Verplancke active positions
| Companies | Position | Start |
|---|---|---|
| MATERIALISE NV | Director/Board Member | 2015-06-08 |
| MDXHEALTH SA | Director/Board Member | 2017-05-25 |
| Fondation contre le Cancer | Director/Board Member | - |
Former positions of Godelieve Verplancke
| Companies | Position | End |
|---|---|---|
| Qaly-Co BV | Founder | 2019-12-31 |
| Qaly | Chief Executive Officer | 2019-12-31 |
Bristol-Myers Squibb Belgium SA
 Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Corporate Officer/Principal | 2011-12-31 |
| Stichting Tegen Kanker | Director/Board Member | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Training of Godelieve Verplancke
| Katholieke Universiteit Leuven | Doctorate Degree |
| University of Antwerp | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| MDXHEALTH SA | Health Technology |
| MATERIALISE NV | Technology Services |
| Private companies | 8 |
|---|---|
Euronext Brussels SA/NV
 Euronext Brussels SA/NV Investment Banks/BrokersFinance Euronext Brussels SA/NV operates a stock exchange. It provides services for regulated stock and derivatives markets in Belgium. The company also offers services, such as facilitating public offerings, providing trading facilities for cash & derivatives products and supplying market data. Euronext Brussels was founded in 1801 and is headquartered in Brussels, Belgium. | Finance |
Quest for Growth NV
 Quest for Growth NV Investment ManagersFinance Quest for Growth NV, a fund traded on Euronext Brussels, has a diversified portfolio which is invested in growth companies listed on European stock exchanges, in European unquoted companies and in venture capital funds. It targets companies operating in the fields of healthcare, healthy living, well-being, human development, smart industries, digitalisation and clean technology & sustainable chemistry. It provides financing for growth stage capital requirements. It also makes co-investments. | Finance |
Bristol-Myers Squibb Belgium SA
Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Health Technology |
| Stichting Tegen Kanker | Miscellaneous |
| Qaly | |
| Imelda Hospital | |
| Fondation contre le Cancer | Miscellaneous |
| Qaly-Co BV |
- Stock Market
- Insiders
- Godelieve Verplancke
